Long CA - Search Results

1

Malaria vaccines and human immune responses.

Long CA, Zavala F. Long CA, et al. Curr Opin Microbiol. 2016 Aug;32:96-102. doi: 10.1016/j.mib.2016.04.006. Epub 2016 Jun 2. Curr Opin Microbiol. 2016. PMID: 27262417 Free PMC article. Review.

2

Immunity to blood stages of malaria.

Long CA. Long CA. Curr Opin Immunol. 1993 Aug;5(4):548-56. doi: 10.1016/0952-7915(93)90036-r. Curr Opin Immunol. 1993. PMID: 8216931 Review.

3

Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.

Calvo PA, Daly TM, Long CA. Calvo PA, et al. Among authors: long ca. Exp Parasitol. 1996 Jan;82(1):54-64. doi: 10.1006/expr.1996.0007. Exp Parasitol. 1996. PMID: 8617331

4

Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.

Kang Y, Calvo PA, Daly TM, Long CA. Kang Y, et al. Among authors: long ca. J Immunol. 1998 Oct 15;161(8):4211-9. J Immunol. 1998. PMID: 9780195

5

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.

Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH. Stowers AW, et al. Among authors: long ca. Infect Immun. 2001 Mar;69(3):1536-46. doi: 10.1128/IAI.69.3.1536-1546.2001. Infect Immun. 2001. PMID: 11179324 Free PMC article.

6

Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.

Hisaeda H, Saul A, Reece JJ, Kennedy MC, Long CA, Miller LH, Stowers AW. Hisaeda H, et al. Among authors: long ca. J Infect Dis. 2002 Mar 1;185(5):657-64. doi: 10.1086/339187. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865423

7

Parasitology. Malaria--from infants to genomics to vaccines.

Long CA, Hoffman SL. Long CA, et al. Science. 2002 Jul 19;297(5580):345-7. doi: 10.1126/science.1074484. Science. 2002. PMID: 12130768 No abstract available.

8

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.

Stowers AW, Kennedy MC, Keegan BP, Saul A, Long CA, Miller LH. Stowers AW, et al. Among authors: long ca. Infect Immun. 2002 Dec;70(12):6961-7. doi: 10.1128/IAI.70.12.6961-6967.2002. Infect Immun. 2002. PMID: 12438375 Free PMC article.

9

Preparation, crystallization and preliminary X-ray analysis of a complex between the Plasmodium vivax sexual stage 25 kDa protein Pvs25 and a malaria transmission-blocking antibody Fab fragment.

Saxena AK, Singh K, Long CA, Garboczi DN. Saxena AK, et al. Among authors: long ca. Acta Crystallogr D Biol Crystallogr. 2004 Nov;60(Pt 11):2054-7. doi: 10.1107/S0907444904021584. Epub 2004 Oct 20. Acta Crystallogr D Biol Crystallogr. 2004. PMID: 15502325

10

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A. Malkin EM, et al. Among authors: long ca. Vaccine. 2005 May 2;23(24):3131-8. doi: 10.1016/j.vaccine.2004.12.019. Vaccine. 2005. PMID: 15837212 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page